Hong Kong
· Delayed Price · Currency is HKD Shanghai Henlius Biotech Statistics
Total Valuation
HKG:2696 has a market cap or net worth of HKD 17.96 billion. The enterprise value is 20.98 billion.
| Market Cap | 17.96B |
| Enterprise Value | 20.98B |
Important Dates
The last earnings date was Sunday, March 23, 2025.
| Earnings Date | Mar 23, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
HKG:2696 has 543.49 million shares outstanding. The number of shares has increased by 0.02% in one year.
| Current Share Class | n/a |
| Shares Outstanding | 543.49M |
| Shares Change (YoY) | +0.02% |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 0.59% |
| Owned by Institutions (%) | 5.71% |
| Float | 68.28M |
Valuation Ratios
The trailing PE ratio is 20.57.
| PE Ratio | 20.57 |
| Forward PE | n/a |
| PS Ratio | 2.95 |
| PB Ratio | 5.60 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | 24.03 |
| EV / Sales | 3.44 |
| EV / EBITDA | 17.20 |
| EV / EBIT | 22.75 |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.50, with a Debt / Equity ratio of 1.21.
| Current Ratio | 0.50 |
| Quick Ratio | 0.34 |
| Debt / Equity | 1.21 |
| Debt / EBITDA | 3.18 |
| Debt / FCF | n/a |
| Interest Coverage | 7.05 |
Financial Efficiency
Return on equity (ROE) is 31.52% and return on invested capital (ROIC) is 8.37%.
| Return on Equity (ROE) | 31.52% |
| Return on Assets (ROA) | 5.28% |
| Return on Invested Capital (ROIC) | 8.37% |
| Return on Capital Employed (ROCE) | 15.57% |
| Revenue Per Employee | 1.73M |
| Profits Per Employee | 248,399 |
| Employee Count | 3,515 |
| Asset Turnover | 0.56 |
| Inventory Turnover | 2.07 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +131.12% in the last 52 weeks. The beta is 0.85, so HKG:2696's price volatility has been lower than the market average.
| Beta (5Y) | 0.85 |
| 52-Week Price Change | +131.12% |
| 50-Day Moving Average | 25.56 |
| 200-Day Moving Average | 23.00 |
| Relative Strength Index (RSI) | 58.16 |
| Average Volume (20 Days) | 1,649,129 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, HKG:2696 had revenue of HKD 6.09 billion and earned 873.12 million in profits. Earnings per share was 1.61.
| Revenue | 6.09B |
| Gross Profit | 4.45B |
| Operating Income | 922.11M |
| Pretax Income | 900.16M |
| Net Income | 873.12M |
| EBITDA | 1.22B |
| EBIT | 922.11M |
| Earnings Per Share (EPS) | 1.61 |
Balance Sheet
The company has 865.95 million in cash and 3.88 billion in debt, giving a net cash position of -3.02 billion or -5.55 per share.
| Cash & Cash Equivalents | 865.95M |
| Total Debt | 3.88B |
| Net Cash | -3.02B |
| Net Cash Per Share | -5.55 |
| Equity (Book Value) | 3.21B |
| Book Value Per Share | 5.90 |
| Working Capital | -2.68B |
Cash Flow
| Operating Cash Flow | n/a |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
Gross margin is 73.10%, with operating and profit margins of 15.14% and 14.33%.
| Gross Margin | 73.10% |
| Operating Margin | 15.14% |
| Pretax Margin | 14.78% |
| Profit Margin | 14.33% |
| EBITDA Margin | 20.02% |
| EBIT Margin | 15.14% |
| FCF Margin | n/a |
Dividends & Yields
HKG:2696 does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.02% |
| Shareholder Yield | -0.02% |
| Earnings Yield | 4.86% |
| FCF Yield | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | n/a |